Literature DB >> 3661119

Aluminum accumulation in tangle-bearing neurons of Alzheimer's disease with Balint's syndrome in a long-term aluminum refiner.

S Kobayashi1, N Hirota, K Saito, M Utsuyama.   

Abstract

Progressive dementia had developed since the age of 55 in a male patient, who had worked as an aluminum refiner for 30 years. Balint's syndrome was observed from at 60 and he died of bronchopneumonia at 65. Neuropathological examination revealed characteristic features of Alzheimer's disease with marked atrophy of the occipito-temporal lobes and senile plaques of the cerebellum. Wavelength-dispersive X-ray microanalysis disclosed focal aluminum accumulation within the nucleus and cytoplasm of the tangle-bearing neurons. Microanalysis by the same method failed to disclose aluminum accumulation in the tangle-bearing neurons in a case of senile dementia of Alzheimer's type who had no possible inhalation of aluminum.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3661119     DOI: 10.1007/bf00688337

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  17 in total

1.  EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATION 2. ELECTRON MICROSCOPY, PHOSPHATASE HISTOCHEMISTRY AND ELECTRON PROBE ANALYSIS.

Authors:  R D TERRY; C PENA
Journal:  J Neuropathol Exp Neurol       Date:  1965-04       Impact factor: 3.685

2.  EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATION. I. LIGHT MICROSCOPIC OBSERVATIONS.

Authors:  I KLATZO; H WISNIEWSKI; E STREICHER
Journal:  J Neuropathol Exp Neurol       Date:  1965-04       Impact factor: 3.685

3.  Neurofibrillary pathology.

Authors:  H Wiśniewski; R D Terry; A Hirano
Journal:  J Neuropathol Exp Neurol       Date:  1970-04       Impact factor: 3.685

4.  Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons.

Authors:  D P Perl; A R Brody
Journal:  Science       Date:  1980-04-18       Impact factor: 47.728

5.  Application of histological sections to wavelength-dispersive X-ray microanalysis.

Authors:  M Utsuyama; Y Kimula
Journal:  J Electron Microsc (Tokyo)       Date:  1980

6.  Aluminium, neurofibrillary degeneration and Alzheimer's disease.

Authors:  D R Crapper; S S Krishnan; S Quittkat
Journal:  Brain       Date:  1976-03       Impact factor: 13.501

7.  Brain aluminum in aging and Alzheimer disease.

Authors:  J R McDermott; A I Smith; K Iqbal; H M Wisniewski
Journal:  Neurology       Date:  1979-06       Impact factor: 9.910

8.  Presenile Alzheimer disease: amyloid plaques in the cerebellum.

Authors:  J D Pro; C H Smith; S M Sumi
Journal:  Neurology       Date:  1980-08       Impact factor: 9.910

9.  Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy, and experimental aluminum encephalopathy.

Authors:  D R Crapper; S Quittkat; S S Krishnan; A J Dalton; U De Boni
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

10.  Brain-aluminium concentration in dialysis encephalopathy.

Authors:  J R McDermott; A I Smith; M K Ward; I S Parkinson; D N Kerr
Journal:  Lancet       Date:  1978-04-29       Impact factor: 79.321

View more
  8 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

2.  Posterior cortical atrophy: Unique features.

Authors:  T Tom; J L Cummings; J Pollak
Journal:  Neurocase       Date:  1998-01       Impact factor: 0.881

3.  Posterior cortical atrophy in Alzheimer's disease: analysis of a new case and re-evaluation of a historical report.

Authors:  P R Hof; N Archin; A P Osmand; J H Dougherty; C Wells; C Bouras; J H Morrison
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

4.  Aluminium-induced tangles in cultured rat neurones. Enhanced effect of aluminium by addition of maltol.

Authors:  D Langui; A Probst; B Anderton; J P Brion; J Ulrich
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

5.  Run-on gene transcription in human neocortical nuclei. Inhibition by nanomolar aluminum and implications for neurodegenerative disease.

Authors:  W J Lukiw; H J LeBlanc; L A Carver; D R McLachlan; N G Bazan
Journal:  J Mol Neurosci       Date:  1998-08       Impact factor: 3.444

6.  Alzheimer's disease: differences in technetium-99m HMPAO SPECT scan findings between early onset and late onset dementia.

Authors:  P M Kemp; C Holmes; S M A Hoffmann; L Bolt; R Holmes; J Rowden; J S Fleming
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-06       Impact factor: 10.154

7.  Bioaccumulation of water soluble aluminium chloride in the hippocampus after transdermal uptake in mice.

Authors:  R Anane; M Bonini; J M Grafeille; E E Creppy
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

8.  Cognitive deterioration and associated pathology induced by chronic low-level aluminum ingestion in a translational rat model provides an explanation of Alzheimer's disease, tests for susceptibility and avenues for treatment.

Authors:  J R Walton
Journal:  Int J Alzheimers Dis       Date:  2012-07-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.